Engineering Organ-on-a-Chip to Accelerate Translational Research.

Micromachines (Basel)

Department of Mechanical Engineering, Seoul National University, Seoul 08826, Korea.

Published: July 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We guide the use of organ-on-chip technology in tissue engineering applications. Organ-on-chip technology is a form of microengineered cell culture platform that elaborates the in-vivo like organ or tissue microenvironments. The organ-on-chip platform consists of microfluidic channels, cell culture chambers, and stimulus sources that emulate the in-vivo microenvironment. These platforms are typically engraved into an oxygen-permeable transparent material. Fabrication of these materials requires the use of microfabrication strategies, including soft lithography, 3D printing, and injection molding. Here we provide an overview of what is an organ-on-chip platform, where it can be used, what it is composed of, how it can be fabricated, and how it can be operated. In connection with this topic, we also introduce an overview of the recent applications, where different organs are modeled on the microscale using this technology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412404PMC
http://dx.doi.org/10.3390/mi13081200DOI Listing

Publication Analysis

Top Keywords

organ-on-chip technology
8
cell culture
8
organ-on-chip platform
8
engineering organ-on-a-chip
4
organ-on-a-chip accelerate
4
accelerate translational
4
translational guide
4
organ-on-chip
4
guide organ-on-chip
4
technology tissue
4

Similar Publications

Dynamic alteration of blood vessel geometry is an inherent feature of the circulatory system. However, while the engineering of multiscale, branched, and interconnected blood vessels has been well explored, mimicking the dynamic behavior (e.g.

View Article and Find Full Text PDF

Innovative engineering approaches to model host-microbiome interactions in vitro.

Adv Drug Deliv Rev

September 2025

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, United States; Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States. Electronic address:

The human microbiome plays a critical role in health and disease. Disruptions in microbiota composition or function have been implicated not only as markers but also as drivers of diverse pathologies, creating opportunities for targeted microbiome interventions. Advancing these therapies requires experimental models that can unravel the complex, bidirectional interactions between human tissue and microbial communities.

View Article and Find Full Text PDF

Tear Film-Based Diagnostics and Emerging Tissue Engineering Approaches in Personalized Dry Eye Disease Management.

Semin Ophthalmol

August 2025

Centre for Ocular Regeneration, Brien Holden Eye Research Centre, Champalimaud Translational Centre for Eye Research, LV Prasad Eye Institute, Hyderabad, India.

Purpose: The dry eye disease(DED) is caused by many possible factors, manifesting classical symptoms such as irritation, pain, and visual disturbance, which can severely impact the quality of life.  This review aims to critically evaluate currently available point‑of‑care (POC) diagnostic kits for DED, focusing on osmolarity‑based and biomarker‑based assays, while exploring emerging technologies that promise better precision and personalized management.

Methods: A comprehensive literature survey (2010-2025) was undertaken using PubMed, Scopus, and Google Scholar to identify studies assessing DED pathophysiology, tear film biomarkers, and commercially available diagnostic systems.

View Article and Find Full Text PDF

State-of-the-Art Organ-on-Chip Models and Designs for Medical Applications: A Systematic Review.

Biomimetics (Basel)

August 2025

Postgraduate Programme in Mechatronic Systems, Department of Mechanical Engineering, Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, DF, Brazil.

Unlabelled: Organ-on-a-chip (OoC) devices simulate human organs within a microenvironment, potentially surpassing traditional preclinical methods and paving the way for innovative treatments. A thorough understanding of the current state of OoC design enables the development of more precise and relevant models that replicate not only the structure of organs but also their intricate cellular interactions and responses to external stimuli. This knowledge facilitates the optimization of biomimetic materials and allows for the real-time simulation of physiological microenvironments.

View Article and Find Full Text PDF

Digestive system cancers-including gastric, liver, colorectal, esophageal, and pancreatic malignancies-remain leading causes of cancer death, with treatment resistance posing major challenges in advanced disease. Patient-derived cancer organoids (PDCOs), 3D mini-tumors grown from patient biopsies, have revolutionized personalized oncology by faithfully replicating tumor biology and enabling predictive drug testing for chemotherapy, radiotherapy, targeted therapy, and immunotherapy. While demonstrating good predictive accuracy, current limitations include incomplete tumor microenvironments, variable establishment rates, and lengthy processing times.

View Article and Find Full Text PDF